Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 46 | 133 | 27 | 3 | 17 | 207 |
Leukemia | D007938 | — | C95 | 50 | 103 | 16 | 3 | 13 | 164 |
Myeloid leukemia acute | D015470 | — | C92.0 | 42 | 74 | 23 | 1 | 9 | 130 |
Myelodysplastic syndromes | D009190 | — | D46 | 41 | 78 | 16 | 1 | 12 | 125 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 30 | 60 | 32 | 11 | 8 | 125 |
Multiple myeloma | D009101 | — | C90.0 | 26 | 63 | 13 | 1 | 12 | 101 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 16 | 48 | 7 | 2 | 10 | 76 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 19 | 46 | 11 | 2 | 7 | 73 |
Neoplasms | D009369 | — | C80 | 33 | 19 | 7 | 1 | 3 | 58 |
Neuroblastoma | D009447 | EFO_0000621 | — | 22 | 21 | 11 | 1 | 3 | 55 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoma | D012509 | — | — | 16 | 35 | 10 | — | 2 | 58 |
Hodgkin disease | D006689 | — | C81 | 11 | 37 | 8 | — | 3 | 52 |
Central nervous system neoplasms | D016543 | — | — | 17 | 28 | 5 | — | 1 | 47 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 22 | 27 | 3 | — | 3 | 45 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 14 | 19 | 3 | — | 4 | 33 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 9 | 16 | 2 | — | 5 | 29 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 5 | 20 | 3 | — | 2 | 28 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 17 | 3 | — | 4 | 25 |
Follicular lymphoma | D008224 | — | C82 | 10 | 14 | 3 | — | 3 | 24 |
Myeloproliferative disorders | D009196 | — | D47.1 | 9 | 10 | 2 | — | 5 | 24 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Mantle-cell lymphoma | D020522 | — | C83.1 | 8 | 15 | — | — | 3 | 22 |
Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 5 | 9 | — | — | 2 | 15 |
Hiv infections | D015658 | EFO_0000764 | B20 | 3 | 5 | — | — | 4 | 12 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 6 | 6 | — | — | 1 | 11 |
Biphenotypic leukemia acute | D015456 | — | C95.0 | 6 | 9 | — | — | — | 11 |
Fanconi anemia | D005199 | Orphanet_84 | D61.09 | 5 | 8 | — | — | 1 | 11 |
Fallopian tube neoplasms | D005185 | — | — | 6 | 3 | — | — | 1 | 9 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 3 | — | — | 3 | 8 |
Waldenstrom macroglobulinemia | D008258 | HP_0005508 | C88.0 | 3 | 4 | — | — | 2 | 8 |
Ewing sarcoma | D012512 | EFO_0000173 | — | 4 | 2 | — | — | 2 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hairy cell leukemia | D007943 | — | C91.4 | 1 | — | — | — | 3 | 4 |
Astrocytoma | D001254 | EFO_0000271 | — | 3 | — | — | — | — | 3 |
Primitive neuroectodermal tumors | D018242 | — | — | 2 | — | — | — | 1 | 3 |
Coronary artery disease | D003324 | — | I25.1 | 1 | — | — | — | 2 | 3 |
Neoplasms by histologic type | D009370 | — | — | 2 | — | — | — | — | 2 |
Glioma | D005910 | EFO_0000520 | — | 2 | — | — | — | — | 2 |
Rhabdoid tumor | D018335 | — | — | 2 | — | — | — | — | 2 |
Oligodendroglioma | D009837 | EFO_0000631 | — | 2 | — | — | — | — | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | — | — | — | 1 | 2 |
Juvenile arthritis | D001171 | EFO_1002007 | M08 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 2 | 2 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | — | — | — | — | 2 | 2 |
Intermittent claudication | D007383 | EFO_0003876 | I73.9 | — | — | — | — | 1 | 1 |
Lupus nephritis | D008181 | EFO_0005761 | — | — | — | — | — | 1 | 1 |
Chediak-higashi syndrome | D002609 | Orphanet_167 | D72.0 | — | — | — | — | 1 | 1 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | — | — | — | — | 1 | 1 |
Giant cell arteritis | D013700 | EFO_1001209 | M31.6 | — | — | — | — | 1 | 1 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | — | — | — | 1 | 1 |
Churg-strauss syndrome | D015267 | EFO_0007208 | M30.1 | — | — | — | — | 1 | 1 |
Polyarteritis nodosa | D010488 | EFO_0009012 | M30.0 | — | — | — | — | 1 | 1 |
Drug common name | Lenograstim |
INN | lenograstim |
Description | Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator. It is developed by Chugai Pharmaceuticals under the brand name Granocyte.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109128 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6WS4C399GB (ChemIDplus, GSRS) |